Acetelion on Analysing the business partnership models of mid – sized pharmas with Asian counterparts

Joining us on the 20th of March 2012 at Marina Bay Sands, Singapore is Mr Ravi Sodha, Senior Director, Business Development, Acetelion, Switzerland. He will be presenting at Pharma Partnering & Investments 2012, part of a series of conferences at the 5th Annual BioPharma Asia Convention 2012

Mr Ravi studied in the UK obtaining B.Sc. in Pharmacology, Ph.D. and MBA. He spent several years in Research (London University, Zurich University Hospitals, Ciba Geigy Basel), Clinical Development (SmithKline Beecham) and Sales & Marketing (Novartis). In 1999 Ravi moved to Business Development & Licensing at Novartis, where he spent 8 years in various functions and therapeutic areas. His last responsibility at Novartis was Alliance Management for a Business Franchise and Asia-based job rotation for Business Development activities in the emerging markets, including India, China, Korea and Taiwan. Ravi joined Actelion Pharma Switzerland in 2008 as Senior Director, Business Development, where his responsibilities include structuring and negotiating licensing deals across several therapeutic areas.

Mr Sodha will be speaking on the following:

Analysing the business partnership models of mid – sized pharmas with Asian counterparts
1. Exploring key strategies and partnership models small to mid-sized pharmas should adopt to position themselves for the best deal value
2. Assessing key challenges on partnership with Asian counterparts
3. Recognizing sectors in Asia that possibly reap high ROI

If you are keen to find out more, join us at BioPharma Asia Convention 2012 to gain valuable insights from more than 200 experts. Contact us now for more details!

Leave a Reply

Your email address will not be published. Required fields are marked *